Jennifer A Schwanekamp1, Angela Lorts1, Ronald J Vagnozzi1, Davy Vanhoutte1, Jeffery D Molkentin2. 1. From the Department of Pediatrics (J.A.S., A.L., R.J.V., D.V., J.D.M.) and Howard Hughes Medical Institute (J.D.M.), Cincinnati Children's Hospital Medical Center, University of Cincinnati, OH. 2. From the Department of Pediatrics (J.A.S., A.L., R.J.V., D.V., J.D.M.) and Howard Hughes Medical Institute (J.D.M.), Cincinnati Children's Hospital Medical Center, University of Cincinnati, OH. Jeff.Molkentin@cchmc.org.
Abstract
OBJECTIVE: Periostin is a secreted protein that can alter extracellular matrix remodeling in response to tissue injury. However, the functional role of periostin in the development of atherosclerotic plaques has yet to be described despite its observed induction in diseased vessels and presence in the serum. APPROACH AND RESULTS: Hyperlipidemic, apolipoprotein E-null mice (ApoE(-/) (-)) were crossed with periostin (Postn(-/-)) gene-deleted mice and placed on a high-fat diet for 6 or 14 weeks to induce atherosclerosis. En face analysis of aortas showed significantly decreased lesion areas of ApoE(-/-) Postn(-/-) mice compared with ApoE(-/-) mice, as well as a reduced inflammatory response with less macrophage content. Moreover, diseased aortas from ApoE(-/-) Postn(-/-) mice displayed a disorganized extracellular matrix with less collagen cross linking and smaller fibrotic caps, as well as increased matrix metalloproteinase-2, metalloproteinase-13, and procollagen-lysine, 2-oxoglutarate 5-dioxygenase-1 mRNA expression. Furthermore, the loss of periostin was associated with a switch in vascular smooth muscle cells toward a more proliferative and synthetic phenotype. Mechanistically, the loss of periostin reduced macrophage recruitment by transforming growth factor-β in cellular migration assays. CONCLUSIONS: These are the first genetic data detailing the function of periostin as a regulator of atherosclerotic lesion formation and progression. The data suggest that periostin could be a therapeutic target for atherosclerotic plaque formation through modulation of the immune response and extracellular matrix remodeling.
OBJECTIVE:Periostin is a secreted protein that can alter extracellular matrix remodeling in response to tissue injury. However, the functional role of periostin in the development of atherosclerotic plaques has yet to be described despite its observed induction in diseased vessels and presence in the serum. APPROACH AND RESULTS: Hyperlipidemic, apolipoprotein E-null mice (ApoE(-/) (-)) were crossed with periostin (Postn(-/-)) gene-deleted mice and placed on a high-fat diet for 6 or 14 weeks to induce atherosclerosis. En face analysis of aortas showed significantly decreased lesion areas of ApoE(-/-) Postn(-/-)mice compared with ApoE(-/-) mice, as well as a reduced inflammatory response with less macrophage content. Moreover, diseased aortas from ApoE(-/-) Postn(-/-)mice displayed a disorganized extracellular matrix with less collagen cross linking and smaller fibrotic caps, as well as increased matrix metalloproteinase-2, metalloproteinase-13, and procollagen-lysine, 2-oxoglutarate 5-dioxygenase-1 mRNA expression. Furthermore, the loss of periostin was associated with a switch in vascular smooth muscle cells toward a more proliferative and synthetic phenotype. Mechanistically, the loss of periostin reduced macrophage recruitment by transforming growth factor-β in cellular migration assays. CONCLUSIONS: These are the first genetic data detailing the function of periostin as a regulator of atherosclerotic lesion formation and progression. The data suggest that periostin could be a therapeutic target for atherosclerotic plaque formation through modulation of the immune response and extracellular matrix remodeling.
Authors: Christopher G Elliott; Jian Wang; Xiaolei Guo; Shi-wen Xu; Mark Eastwood; Jianjun Guan; Andrew Leask; Simon J Conway; Douglas W Hamilton Journal: J Cell Sci Date: 2012-01-20 Impact factor: 5.285
Authors: K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo Journal: J Bone Miner Res Date: 1999-07 Impact factor: 6.741
Authors: Yuri V Bobryshev; Murray C Killingsworth; Thuan G Huynh; Reginald S A Lord; Anthony J Grabs; Stella M Valenzuela Journal: Basic Res Cardiol Date: 2006-12-01 Impact factor: 17.165
Authors: Carolina Bagnato; Jaykumar Thumar; Viveka Mayya; Sun-Il Hwang; Henry Zebroski; Kevin P Claffey; Christian Haudenschild; Jimmy K Eng; Deborah H Lundgren; David K Han Journal: Mol Cell Proteomics Date: 2007-03-05 Impact factor: 5.911
Authors: Volkhard Lindner; Qiaozeng Wang; Barbara A Conley; Robert E Friesel; Calvin P H Vary Journal: Arterioscler Thromb Vasc Biol Date: 2004-10-28 Impact factor: 8.311
Authors: P K Shah; E Falk; J J Badimon; A Fernandez-Ortiz; A Mailhac; G Villareal-Levy; J T Fallon; J Regnstrom; V Fuster Journal: Circulation Date: 1995-09-15 Impact factor: 29.690
Authors: Jason L Johnson; Laurent Devel; Bertrand Czarny; Sarah J George; Christopher L Jackson; Vassilis Rogakos; Fabrice Beau; Athanasios Yiotakis; Andrew C Newby; Vincent Dive Journal: Arterioscler Thromb Vasc Biol Date: 2011-01-06 Impact factor: 8.311
Authors: John T Walker; Karrington McLeod; Shawna Kim; Simon J Conway; Douglas W Hamilton Journal: Cell Tissue Res Date: 2016-05-28 Impact factor: 5.249
Authors: Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311